Pulmonary Hypertension

Part of the Medical Radiology book series (MEDRAD)


In this chapter the basics of MRI physics will be addressed. It will start with an overview of MR signal generation and relaxation. Then the concept of magnetization preparation will be explored in the context of cardiac imaging. The next sections will address the physics behind spatial encoding and motion compensation. Finally specific cardiac MRI sequences will be discussed including a discussion of optimization. By the end of the chapter the reader should have a better understanding of basic MRI physics and a greater ability to optimise sequences.


Pulmonary Hypertension Right Ventricular Pulmonary Arterial Hypertension Interventricular Septum Right Ventricular Ejection Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alunni JP, Degano B, Arnaud C, Tetu L, Blot-Souletie N, Didier A, Otal P, Rousseau H, Chabbert V (2010) Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 20:1149–1159PubMedCrossRefGoogle Scholar
  2. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, Mcgoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54:S55–S66PubMedCrossRefGoogle Scholar
  3. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993–1999PubMedCrossRefGoogle Scholar
  4. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, Desoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179:151–157PubMedCrossRefGoogle Scholar
  5. D’alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–349PubMedGoogle Scholar
  6. Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, Macaluso F, Fuster V, Rajagopalan S (2007) Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 243:63–69PubMedCrossRefGoogle Scholar
  7. Galie N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A (2009) A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 30:394–403PubMedCrossRefGoogle Scholar
  8. Galie N, Rubin L, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371:2093–2100PubMedCrossRefGoogle Scholar
  9. Gan CT, Lankhaar JW, Westerhof N, Marcus JT, Becker A, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A (2007) Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 132:1906–1912PubMedCrossRefGoogle Scholar
  10. Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, Hill C, Akil M, Wild JM, Kiely DG (2009) Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) 48:1137–1142CrossRefGoogle Scholar
  11. Hardziyenka M, Campian ME, Reesink HJ, Surie S, Bouma BJ, Groenink M, Klemens CA, Beekman L, Remme CA, Bresser P, Tan HL (2011) Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass evidence for atrophic remodeling. J Am Coll Cardiol 57:921–928PubMedCrossRefGoogle Scholar
  12. Hardziyenka M, Reesink HJ, Bouma BJ, de Bruin-bon HA, Campian ME, Tanck MW, van den Brink RB, Kloek JJ, Tan HL, Bresser P (2007) A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J 28:842–849PubMedCrossRefGoogle Scholar
  13. Hoeper MM, Tongers J, Leppert A, Baus S, Maier R, Lotz J (2001) Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. Chest 120:502–507PubMedCrossRefGoogle Scholar
  14. Houde C, Bohn DJ, Freedom RM, Rabinovitch M (1993) Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 70:461–468PubMedCrossRefGoogle Scholar
  15. Jardim C, Rochitte CE, Humbert M, Rubenfeld G, Jasinowodolinski D, Carvalho CR, Souza R (2007) Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J 29:476–481PubMedCrossRefGoogle Scholar
  16. Jauhiainen T, Jarvinen VM, Hekali PE (2002) Evaluation of methods for MR imaging of human right ventricular heart volumes and mass. Acta Radiol 43:587–592PubMedCrossRefGoogle Scholar
  17. Katz J, Whang J, Boxt LM, Barst RJ (1993) Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol 21:1475–1481PubMedCrossRefGoogle Scholar
  18. Kind T, Mauritz GJ, Marcus JT, van de Veerdonk M, Westerhof N, Vonk-Noordegraaf A (2010) Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson 12:35PubMedCrossRefGoogle Scholar
  19. Kon MW, Myerson SG, Moat NE, Pennell DJ (2004) Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 13:600–607PubMedGoogle Scholar
  20. Kreitner KF, Kunz RP, Ley S, Oberholzer K, Neeb D, Gast KK, Heussel CP, Eberle B, Mayer E, Kauczor HU, Duber C (2007) Chronic thromboembolic pulmonary hypertension—assessment by magnetic resonance imaging. Eur Radiol 17:11–21PubMedCrossRefGoogle Scholar
  21. Kreitner KF, Ley S, Kauczor HU, Mayer E, Kramm T, Pitton MB, Krummenauer F, Thelen M (2004) Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 232:535–543PubMedCrossRefGoogle Scholar
  22. Ley S, Mereles D, Puderbach M, Gruenig E, Schock H, Eichinger M, Ley-Zaporozhan J, Fink C, Kauczor HU (2007) Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol 17:1892–1897PubMedCrossRefGoogle Scholar
  23. Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ (2011) Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol 58:538–546PubMedCrossRefGoogle Scholar
  24. Lurz P, Nordmeyer J, Coats L, Taylor AM, Bonhoeffer P, Schulze-Neick I (2009) Immediate clinical and haemodynamic benefits of restoration of pulmonary valvar competence in patients with pulmonary hypertension. Heart 95:646–650PubMedCrossRefGoogle Scholar
  25. Marcus JT, Gan CT, Zwanenburg JJ, Boonstra A, Allaart CP, Gotte MJ, Vonk-Noordegraaf A (2008) Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 51:750–757PubMedCrossRefGoogle Scholar
  26. Mauritz GJ, Marcus JT, Boonstra A, Postmus PE, Westerhof N, Vonk-Noordegraaf A (2008) Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson 10:51PubMedCrossRefGoogle Scholar
  27. Minai OA, Chaouat A, Adnot S (2010) Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 137:39S–51SPubMedCrossRefGoogle Scholar
  28. Moledina S, Hislop AA, Foster H, Schulze-Neick I, Haworth SG (2010) Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart 96:1401–1406PubMedCrossRefGoogle Scholar
  29. Muthurangu V, Lurz P, Critchely JD, Deanfield JE, Taylor AM, Hansen MS (2008) Real-time assessment of right and left ventricular volumes and function in patients with congenital heart disease by using high spatiotemporal resolution radial k-t SENSE. Radiology 248:782–791PubMedCrossRefGoogle Scholar
  30. Nogami M, Ohno Y, Koyama H, Kono A, Takenaka D, Kataoka T, Kawai H, Kawamitsu H, Onishi Y, Matsumoto K, Matsumoto S, Sugimura K (2009) Utility of phase contrast MR imaging for assessment of pulmonary flow and pressure estimation in patients with pulmonary hypertension: comparison with right heart catheterization and echocardiography. J Magn Reson Imaging 30:973–980PubMedCrossRefGoogle Scholar
  31. Reiter G, Reiter U, Kovacs G, Kainz B, Schmidt K, Maier R, Olschewski H, Rienmueller R (2008) Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 1:23–30PubMedCrossRefGoogle Scholar
  32. Roeleveld RJ, Marcus JT, Boonstra A, Postmus PE, Marques KM, Bronzwaer JG, Vonk-Noordegraaf A (2005a) A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 22:67–72PubMedCrossRefGoogle Scholar
  33. Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE, Vonk-Noordegraaf A (2005b) Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234:710–717PubMedCrossRefGoogle Scholar
  34. Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, Bronzwaer JG, Marques KM, Postmus PE, Boonstra A (2004) Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 125:572–579PubMedCrossRefGoogle Scholar
  35. Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ (2002) Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 20:1519–1524PubMedCrossRefGoogle Scholar
  36. Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, Rajagopalan S (2009) Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2:286–295PubMedCrossRefGoogle Scholar
  37. Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein AJ, Dellegrottaglie S, Fuster V, Rajagopalan S, Poon M (2007) Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 243:70–79PubMedCrossRefGoogle Scholar
  38. Shehata ML, Lossnitzer D, Skrok J, Boyce D, Lechtzin N, Mathai SC, Girgis RE, Osman N, Lima JA, Bluemke DA, Hassoun PM, Vogel-Claussen J (2011) Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. Am J Roentgenol 196:87–94CrossRefGoogle Scholar
  39. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43–S54PubMedCrossRefGoogle Scholar
  40. Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Jablonski KA, Leeper KV Jr, Naidich DP, Sak DJ, Sostman HD, Tapson VF, Weg JG, Woodard PK (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434–443 W142-3PubMedGoogle Scholar
  41. Stein PD, Woodard PK, Hull RD, Kayali F, Weg JG, Olson RE, Fowler SE (2003) Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review. Chest 124:2324–2328PubMedCrossRefGoogle Scholar
  42. Tardivon AA, Mousseaux E, Brenot F, Bittoun J, Jolivet O, Bourroul E, Duroux P (1994) Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging. Am J Respir Crit Care Med 150:1075–1080PubMedGoogle Scholar
  43. Urboniene D, Haber I, Fang YH, Thenappan T, Archer SL (2010) Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 299:L401–L412PubMedCrossRefGoogle Scholar
  44. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A (2007) Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28:1250–1257PubMedCrossRefGoogle Scholar
  45. Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS (2005) Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study. Am J Respir Crit Care Med 171:1292–1297PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.UCL Centre for Cardiovascular Imaging and Great Ormond Street Hospital for ChildrenLondonUK
  2. 2.Cardio-respiratory UnitGreat Ormond Street Hospital for ChildrenLondonUK

Personalised recommendations